Xenetic Biosciences (XBIO) Preferred Shares (2016 - 2026)
Xenetic Biosciences' (XBIO) quarterly Preferred Shares came in at $1454.0 in Q1 2026, down 19.4% YoY from $1804.0 in Q1 2025, and little changed on a QoQ basis from $1454.0 in Q4 2025.
Xenetic Biosciences (XBIO) Preferred Shares (2016 - 2026) Analysis & Trends
Xenetic Biosciences (XBIO) has 11 years of Preferred Shares data on file, last reported at $1454.0 in Q1 2026.
- Quarterly Preferred Shares fell 19.4% year-over-year to $1454.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1454.0 (down 19.4% YoY) and the FY2025 annual result came in at $1454.0, down 19.4% from the prior year.
- Preferred Shares steadied at $1454.0 in Q1 2026, from $1454.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $1804.0 in Q1 2022 to a low of $970.0 in Q2 2022.
- A 5-year average of $1566.6 and a median of $1804.0 in 2022 frame the typical range for Preferred Shares.
- The widest YoY moves for Preferred Shares: up 85.98% in 2022, down 34.97% in 2022.
- Tracing XBIO's Preferred Shares over 5 years: stood at $1804.0 in 2022, then changed by 0.0% to $1804.0 in 2023, then changed by 0.0% to $1804.0 in 2024, then slipped by 19.4% to $1454.0 in 2025, then changed by 0.0% to $1454.0 in 2026.
- The last three Preferred Shares figures came in at $1454.0 (Q1 2026), $1454.0 (Q4 2025), and $1804.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Xenetic Biosciences | 8.01 Mn | 1.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,454.00 |
| Dec 31, 2025 | 1,454.00 |
| Sep 30, 2025 | 1,804.00 |
| Jun 30, 2025 | 1,804.00 |
| Mar 31, 2025 | 1,804.00 |
| Dec 31, 2024 | 1,804.00 |
| Sep 30, 2024 | 1,804.00 |
| Jun 30, 2024 | 1,804.00 |
| Mar 31, 2024 | 1,804.00 |
| Dec 31, 2023 | 1,804.00 |
| Sep 30, 2023 | 970.00 |
| Jun 30, 2023 | 970.00 |
| Mar 31, 2023 | 1,804.00 |
| Dec 31, 2022 | 1,804.00 |
| Sep 30, 2022 | 970.00 |
| Jun 30, 2022 | 970.00 |
| Mar 31, 2022 | 1,804.00 |
| Dec 31, 2021 | 970.00 |
| Sep 30, 2021 | 970.00 |
| Jun 30, 2021 | 970.00 |